Virology and Bioinformatics from Virology.ca
81.7K views | +20 today
Follow
Virology and Bioinformatics from Virology.ca
Virus and bioinformatics articles with some microbiology and immunology thrown in for good measure
Your new post is loading...
Your new post is loading...
Scooped by Chris Upton + helpers
Scoop.it!

Best Science podcasts

Best Science podcasts | Virology and Bioinformatics from Virology.ca | Scoop.it
Here are the 20 best science podcasts on the internet, chosen by the GeekWrapped science staff:
more...
No comment yet.
Rescooped by Chris Upton + helpers from Modern Life Science: of computers and men
Scoop.it!

Translational Bioinformatics: Transforming 300 Billion Points of Data

Translational Bioinformatics: Transforming 300 Billion Points of Data into Diagnostics, Therapeutics, and New Insights into Disease Air date: Wednesday, June...

 

LECTURE FROM STANFORD


Via Sandrine Palcy
more...
No comment yet.
Scooped by Chris Upton + helpers
Scoop.it!

Scientists Unearth a Trove of New Bacteria-Killing Viruses

Scientists Unearth a Trove of New Bacteria-Killing Viruses | Virology and Bioinformatics from Virology.ca | Scoop.it
Bacteria prey on humans, but the bugs have to beware of their own predators, too: a special class of viruses called phages.
more...
Rakesh Yashroy's curator insight, September 4, 2015 11:49 AM

Every living organism has an enemy threatening its existence. What is  the threat to bacteriophages? Any reply!#@?

Scooped by Chris Upton + helpers
Scoop.it!

What the Tamiflu saga tells us about drug trials and big pharma

What the Tamiflu saga tells us about drug trials and big pharma | Virology and Bioinformatics from Virology.ca | Scoop.it
Ben Goldacre: We now know the government's Tamiflu stockpile wouldn't have done us much good in the event of a flu epidemic. But the secrecy surrounding clinical trials means there's a lot we don't know about other medicines we take
Chris Upton + helpers's insight:

It's sad that this causes distrust that spills over to vaccines -  which WORK!

more...
No comment yet.